FDA approves treatment for people with mild forms of Alzheimer’s
January 06, 2023 at 14:47 PM EST
Leqembi, which was developed by Eisai and Biogen, will cost about $26,000 a year
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |